DESCRIPTION (provided by applicant): Biothera, Inc. has emerging scientific evidence that orally-administered whole glucan particle (WGP) ?- glucan produces potent immunologic and hematopoietic activities. Such a product could have practical implications as a realistic, publicly-distributable… More

Pancreatic cancer is a "rare" and fata l disease, with few treatment options. Currently, promising antitumor strategies utilize combination therapies, with each agent targeting separate aspects of oncogenesis. Disappointingly, combination of anti- EGFR monoclonal antibody (MAb), cetuximab,… More